Physician profile
Michael Gary Hull
NPI 1952697336
$11,536.10
in general payments reported to CMS, 2019-2025
18 companies · $2,338 in 2025
The $2,338 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,327 · 2020: $1,428 · 2021: $103 · 2022: $4,977 · 2023: $117 · 2024: $1,247 · 2025: $2,338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,316 · Food and Beverage: $1,385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,316.38 |
| Food and Beverage | $1,385.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,833.06 | 2020-2025 | |
| Smith+Nephew, INC. | $3,163.30 | 2022 | |
| United Orthopedics LLC | $2,183.67 | 2019-2025 | |
| Integra Lifesciences Corporation | $941.34 | 2019-2020 | |
| Depuy Synthes Sales INC. | $484.62 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $313.32 | 2019-2025 | Euflexxa |
| Medline Industries LP | $194.58 | 2025 | |
| Bioventus LLC | $125.05 | 2019-2025 | Gelsyn-3, Durolane |
| Ermi LLC | $106.55 | 2019-2023 | |
| Acumed LLC | $48.40 | 2025 | Acumed, Innate Implant |
| Peerless Surgical INC. | $41.77 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $16.51 | 2022 | |
| Avanos Medical | $16.34 | 2023 | Trivisc Sodium Hyaluronate |
| Horizon Therapeutics Plc | $15.74 | 2020 | |
| Bard Peripheral Vascular, INC. | $15.59 | 2025 | Venclose Maven Catheter |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $12.84 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $12.80 | 2020 | |
| Orthofix Medical, INC. | $10.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.